Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested readings
Jennings RB, Steenbergen C Jr, Reimer KA. Myocardial ischemia and reperfusion. Monogr Pathol. 1995; 37:47–80.
Reimer KA, Vander Heide RS, Jennings RB. Ischemic preconditioning slows ischemic metabolism and limits myocardial infarct size. Ann N Y Acad Sci. 1994; 723:99–115.
Jennings RB, Reimer KA. The cell biology of acute myocardial ischemia. Annu Rev Med. 1991; 42:225–46.
Reimer KA, Jennings RB. The “wavefront phenomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest. 1979; 40:633–44.
Brockington CD, Lyden PD. Criteria for selection of older patients for thrombolytic therapy. Clin Geriatr Med. 1999; 15:721–39.
Hamm CW. New serum markers for acute myocardial infarction. N Engl J Med. 1994; 331:607–8.
Straznicky IT, White HD. Thrombolytic therapy for acute myocardial infarction in the elderly. Coron Artery Dis. 2000; 11:299–304.
Zhao M, Zhang H, Robinson TF, Factor SM, Sonneblick H, Eng C. Profound structural alterations of the extracellular collagen matrix in postischemic dysfunctional (“stunned”) but viable myocardium. J Am Coll Cardiol 1987; 10:1322–34.
Factor SM, Bache R. “Pathophysiology of Myocardial Ischemia”. In Hurt’s The Heart. Ninth Edition. Alexander WR, Schlant RC, and Fuster V eds. McGraw-Hill Co, Inc., 1998.
Suggested readings
Levine GN, Ali MN. The role of percutaneous revascularization in the treatment of ischemic heart disease: insights from published reports and randomized clinical trials. Chest. 1997; 112:805–21.
Kawasuji M, Sakakibara N, Takemura H, Tedoriya T, Ushijima T, Watanabe Y. Is internal thoracic artery grafting suitable for a moderately stenotic coronary artery? J Thorac Cardiovasc Surg. 1996; 112:253–9.
Jensen J, Eriksson SV, Lindvall B, Lundin P, Sylven C. Women react with more myocardial ischemia and angina pectoris during elective percutaneous transluminal coronary angioplasty. Coron Artery Dis. 2000; 11:527–35.
Friesinger GC, Ryan TJ. Coronary heart disease. Stable and unstable syndromes. Cardiol Clin. 1999; 17:93–122.
Cishek MB, Gershony G. Roles of percutaneous transluminal coronary angioplasty and bypass graft surgery for the treatment of coronary artery disease. Am Heart J. 1996; 131:1012–7.
Tennant M, McGeachie JK. A biological basis for re-stenosis after percutaneous transluminal angioplasty: possible underlying mechanisms. Aust N Z J Surg. 1992; 62:135-4.
Weiner DA. Significance of silent myocardial ischemia after coronary artery bypass surgery. Am J Cardiol. 1992; 70:35F–38F.
Factor SM, Minase T, Cho S, Fein F, Capasso JM, Sonneblick EH. Coronary microvascular abnormalities in the hypertensive-diabetic rat. A cause of cardiomyopathy? Am J Pathol 1984; 116:9–20.
Suggested readings
Nienaber CA, Von Kodolitsch Y. Therapeutic management of patients with Marfan syndrome: focus on cardiovascular involvement. Cardiol Rev. 1999; 7:332–41.
Libby P, Sukhova G, Lee RT, Liao JK Molecular biology of atherosclerosis. Int J Cardiol. 1997; 62(Suppl 2):S23–9.
Leopold JA, Loscalzo J. Clinical importance of understanding vascular biology Cardiol Rev. 2000; 8:115–23.
Samman B, Korr KS, Katz AS, Parisi AF. Pitfalls in the diagnosis and management of papillary muscle rupture: a study of four cases and review of the literature. Clin Cardiol. 1995; 18:591–6.
Reeder GS. Identification and treatment of complications of myocardial infarction. Mayo Clin Proc. 1995; 70:880–4.
Buda AJ. The role of echocardiography in the evaluation of mechanical complications of acute myocardial infarction. Circulation. 1991; 84 (3 Suppl):I109–21.
Prieto A, Eisenberg J, Thakur RK. Nonarrhythmic complications of acute myocardial infarction. Emerg Med Clin North Am. 2001; 19: 397–415.
Robinson TF, Geraci MA, Sonneblick EH, Factor SM. Coiled perimysial fibers of papillary muscle in rat heart; morphology, distribution, and changes in configuration. Circ Res 1988; 63:577–92.
Suggested readings
Villablanca AC, McDonald JM; Rutledge JC. Smoking and cardiovascular disease. Clin Chest Med. 2000; 21:159–72.
Reimer KA, Jennings RB. Biologic basis for limitation of infarct size. Adv Exp Med Biol. 1986; 194:315–30.
Ravn HB, Falk E. Histopathology of plaque rupture. Cardiol Clin. 1999; 17:263–70.
Schroeder AP, Falk E. Pathophysiology and inflammatory aspects of plaque rupture. Cardiol Clin. 1996; 14:211–20.
Becker RC, Bovill EG, Seghatchian MJ, Samama MM. Pathobiology of thrombin in acute coronary syndromes. Am Heart J. 1998; 136:S19–31
Stern S, Cohn PF, Pepine CJ. Silent myocardial ischemia. Curr Probl Cardiol. 1993; 18:301–59.
Okun EM, Factor SM, Kirk ES. End-capillary loops in the heart: An explanation for discrete myocardial infarctions without border zones. Science 1979; 206:565–67.
Factor SM, Okun EM, Kirk ES. The histological lateral border of acute canine myocardial infarction: a function of the microcirculation. Circ Res 1981; 48:640–49.
Factor SM, Okun EM, Minase T, Kirk ES. The microcirculation of the human heart: end capillary loops with discrete perfusion fields. Circulation 1982; 66:1241–48.
Forman R, Cho S, Factor SM, Kirk ES. Acute myocardial infarct extension into a previously preserved subendocardial region at risk in dogs and patients. Circulation 1982; 67:117–24.
Suggested readings
Hirsh J. Coronary thrombolysis: hemorrhagic complications. Can J Cardiol 1993; 9:505–11.
Sleight P. Thrombolysis: state of the art. Eur Heart J 1993; Suppl G:41–7.
Simoons ML. Risk-benefit of thrombolysis. Cardiol Clin 1995; 13:339–45.
Jafri SM, Walters BL, Borzak S. Medical therapy of acute myocardial infarction: Part I. Role of thrombolytic and antithrombotic therapy. J Intensive Care Med 1995; 10:54–63.
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Lancet 1994; 343:311–22.
Suggested readings
Elming H, Kober L. Spontaneous coronary artery dissection. Case report and literature review. Scand Cardiovasc J. 1999; 33:175–9.
Atay Y, Yagdi T, Turkoglu C, Altintig A, Buket S. Spontaneous dissection of the left main coronary artery: a case report and review of the literature. J Card Surg. 1996; 11:371–5.
Waller BF, Fry ET, Hermiller JB, Peters T, Slack JD. Nonatherosclerotic causes of coronary artery narrowing—Part II. Clin Cardiol. 1996; 19:587–91.
Jouriles NJ. Atypical chest pain. Emerg Med Clin North Am. 1998 Nov; 16:717–40.
Borczuk AC; van Hoeven KH; Factor SM. Review and hypothesis: the eosinophil and peripartum heart disease (myocarditis and coronary artery dissection)—coincidence or pathogenetic significance? Cardiovasc Res. 1997; 33:527–32.
Hahn IH, Hoffman RS. Cocaine use and acute myocardial infarction. Emerg Med Clin North Am. 2001; 19:493–510.
Rump AF, Theisohn M, Klaus W. The pathophysiology of cocaine cardiotoxicity. Forensic Sci Int. 1995; 71:103–15.
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
(2002). Atherosclerotic Heart Disease and Ischemia. In: Handbook of Pathology and Pathophysiology of Cardiovascular Disease. Developments in Cardiovascular Medicine, vol 240. Springer, Boston, MA. https://doi.org/10.1007/0-306-47575-8_2
Download citation
DOI: https://doi.org/10.1007/0-306-47575-8_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-7923-7542-5
Online ISBN: 978-0-306-47575-7
eBook Packages: Springer Book Archive